Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: An Overview. Cold Spring Harb Perspect Med. 2016;6:a027029.
2. Alfieri A, Di Franco S, Donatiello V, Maffei V, Fittipaldi C, Fiore M, et al. Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review. Life. 2022;12:1949.
3. Serio AW, Keepers T, Krause KM. Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae. Open Forum Infect Dis. 2019;6:ofz123.
4. Blanchard LS, Van Belkum A, Dechaume D, Armstrong TP, Emery CL, Ying YX, et al. Multicenter Clinical Evaluation of ETEST Plazomicin (PLZ) for Susceptibility Testing of Enterobacterales. Ledeboer NA. J Clin Microbiol. 2022;60:e01831–21.
5. EUCAST Clinical breakpoints and dosing of antibiotics. 2023. Available at: https://www.eucast.org/clinical_breakpoints. Assessed 3 October 2023.